Breast Biopsy Market Trends

Growth Driver

Increasing Consumption of Unhealthy Foods- Breast cancer is increasing globally due to the increasing consumption of unhealthy and fried foods by women worldwide. One study found that women who regularly ate fried food were 4.5 times more likely to develop breast cancer than other women her age, with a very significant association between highly fried foods and the risk of breast cancer.
Technological Advances in Breast Biopsy Equipment: Technological advances in breast biopsy devices have led to the development of more precise and less invasive procedures. For example, 3D mammography is becoming increasingly popular because it provides higher-resolution images that can detect smaller lesions. One study found that 3D mammography was associated with a 41% increased chance of detecting invasive breast cancer compared with traditional 2D mammography.
Raise Awareness About Breast Cancer Screening: Growing awareness of the importance of early detection and diagnosis of breast cancer, through breast cancer screening, leading to an increase in the number of women undergoing breast biopsy procedures. According to a survey, nearly 75% of women aged 40 and over said they had a mammogram in the past two years.
Increased Spending on Health: Increasing healthcare costs worldwide are driving the growth of the global breast biopsy market. According to a study, global health expenditure was valued at USD 7.1 trillion in 2019 and is expected to reach USD 12.8 trillion by 2026. As healthcare costs continue to rise, more resources will be allocated to breast cancer screening and diagnosis, which will lead to an increase in demand for breast biopsy procedures.

Challenges

High Cost of Breast Biopsy Procedures – Breast biopsy procedures can be expensive, particularly in countries where healthcare costs are high. This can make it difficult for some patients to access the procedure, leading to delays in diagnosis and treatments.
Lack of Awareness and Education
Fear and Discomfort

Breast Biopsy Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	6.5%
Base Year Market Size (2024)	USD 3.4 billion
Forecast Year Market Size (2037)	USD 7.71 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of breast biopsy is estimated at USD 3.58 billion.

The breast biopsy market size was valued at USD 3.4 billion in 2024 and is set to exceed USD 7.71 billion by 2037, registering over 6.5% CAGR during the forecast period i.e., between 2025-2037. The growing incidence of breast cancer and the expansion of healthcare spending will drive the market growth.

Asia Pacific industry is expected to account for largest revenue share of 35% by 2037, impelled by increase in the percentage of the aging population in the region.

The major players in the market include Hologic, Inc., Danaher CorporationBD (Becton, Dickinson, and Company)Cook Medical LLCArgon Medical Devices, Inc.B. Braun Melsungen AGC.R. Bard, Inc.Devicor Medical Products, Inc.Cardinal Health, Inc.

Breast Biopsy Market Trends